SHL Telemedicine Ltd.: SGM Results announced: Majority of the Board replaced; new external director appointed Montag, 10. Dezember 2018 - 16:51

Press release

SGM Results announced: Majority of the Board replaced; new external director appointed

Tel Aviv / Zurich, December 10, 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, is announcing that the Special General Meeting of the Shareholders (the “SGM“) held today in Tel-Aviv (Israel) has, among others:

1. approved the request of Nehama and Yoram Alroy Investment Ltd, to terminate the office of the following board members: (a) Mr. Xuewen Wu, (b) Mr. Cailong Su, (c) Mr. Yi He, (d) Ms. Yirong Qian, (e) Dr. Yuan-Hsun Lo, and (f) Ms. Hava Shechter.
   
2. approved the request of Nehama and Yoram Alroy Investment Ltd to elect the following candidates in place of the directors so removed until the next annual general meeting (the “AGM”): (a) Elon Shalev, (b) Erez Alroy, (c) Yariv Alroy; and (d) Erez Nachtomy; and furthermore rejected the request of GZ Asset Management Ltd. to elect Mr. Ziv Carthy as a board member.
   
3. elected Ms. Dvorah Kimhi as Independent (External) Director to the Board of Directors of the Company, pursuant to Section 239(b) of the Israeli Companies Law, for a three (3) year term.

As a result, the current composition of the Board (by alphabetical order) is as follows: (i) Mr. Shuky Abramovich – an external director elected in June 2017 for a three (3) years term; (ii) Mr. Erez Alroy - elected in the SGM until the next AGM; (iii) Mr. Yariv Alroy elected in the SGM until the next AGM; (iv) Ms. Devorah Kimhi – elected in the SGM for a three (3) years term; (v) Prof. Amir Lerman who remained in office – until the next AGM; (vi) Mr. Erez Nachtomy - elected in the SGM until the next AGM; and (vii) Mr. Elon Shalev – elected in the SGM until the next AGM.

The term of Mr. Wu as Chairman of the Board has terminated with the termination of his office with immediate effect following the SGM. The Board of Directors will have to convene a Board meeting in accordance with Israeli law and SHL’s Articles of Association to elect a new Chairman.

For further information please contact:

Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, shl@irfcom.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.